HomeCardiovascular
Cardiovascular
Evolocumab with statins slashes cholesterol, reduces major CV events
Added to statins, the drug evolocumab decreased major cardiovascular (CV) events by cutting bad cholesterol to unprecedented levels, found the FOURIER trial on 27,000...
Physical activity protects for CVD risk even in the obese
The benefits of physical activity may outweigh the impact of overweight and obesity on cardiovascular disease (CVD) in middle-aged and elderly people, according to...
Pre-eclampsia substantially increases heart disease risk in later life
Pre-eclampsia is associated with a four-fold increase in future incident heart failure and a two-fold increased risk of coronary heart disease, stroke, and death...
Less scarring with new coronary artery graft technique
A new technique for coronary bypass surgery shows a reduction in problematic scar tissue growth, found a Norwegian study.
Surgeons often take a blood vessel from...
New country-specific CVD risk charts
Researchers have produced the first set of risk charts for 182 countries to predict their patients’ 10-year risk of cardiovascular disease (CVD).
These will be...
Beta-blockers not successful in treating hypertension
A Cochrane Review of studies into beta-blockers, mostly atenolol, found that they were not as good at preventing the number of deaths, strokes, and heart...
Novel catheter-based approach for cardiac birth defect
A new minimally invasive technique for repairing the most common cardiac birth defect in extremely premature newborns can be performed safely with a high...
Intense anger increases heart risk eightfold
University of Sydney research has found that the risk of a heart attack is 8.5 times higher in the two hours following a burst of intense anger.
Clot busting medications reduce pulmonary embolism deaths
Bringing clarity to a decades-long debate, researchers led from the Perelman School of Medicine at the University of Pennsylvania found that adding clot-busting medications...